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After its description by Gramiak and Shah (1) at the Univer- 
sity of Rochester, contrast echocardiography was initially 
used mainly for structure identification. This application was 
rapidly rendered obsolete as instrumentation and clinical 
experience with two-dimensional echocardiography im- 
proved. The second major application for contrast echocar- 
diography was the detection of abnormal flow patterns in 
congenital heart disease: shunts, anomalous connections or 
absence of normal functional continuity. Several clinical 
series using contrast echocardiography in congenital heart 
disease were reported in the 1970s (2,3). During the 1980s. 
however, this application has been largely replaced by 
pulsed, continuous and especially Doppler color echocar- 
diography. The review by Van Hare and Silverman (4) in this 
issue of the Journal summarizes their experience with con- 
trast echocardiography in congenital heart disease over the 
past 12 years. It gives a perspective on where contrast 
continues to be useful in the Doppler color flow imaging era. 
Shunts. Contrast studies are very sensitive for detecting 
small shunts at low velocities, such as right to left shunt due 
to patent foramen ovale or persistent fetal circulation. Dop- 
pler echocardiography is better for detecting small high 
velocity shunts such as those due to a left to right shunt 
through a small ventricular septal defect (maladie de Roger). 
Assessment of flow connections. The destination of ve- 
nous blood can be assessed by contrast echocardiography. 
For example, left superior vena cava to coronary sinus 
connection can be demonstrated by contrast echocardiog- 
raphy after injection of contrast medium into the left arm (5). 
Following the course of venous or arterial blood flow can be 
helpful also in more complicated congenital lesions such as 
transposition of the great vessels, tricuspid atresia, hypo- 
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plastic left ventricle and various cardiac situs problems. 
Also, the demonstration of forward flow for the differentia- 
tion between critical pulmonary stenosis and atresia is more 
reliable by contrast than by Doppler echocardiography. The 
same method can be used to confirm interruption of venous 
flow as in interruption of flow in the inferior vena cava. 
Contrast echocardiography is useful to determine the loca- 
tion of the venous atrium in cases of dextrocardia and situs 
inversus. This type of physiologic information cannot be 
obtained by Doppler echocardiography alone. 
Arteriovenous malformations. Arteriovenous fistulas can 
appear in different organs and are usually classified as 
systemic (or peripheral) and pulmonary types. These shunt 
are often difficult to localize by conventional Doppler echo- 
cardiography. Van Hare and Silverman (4), as well as 
previous investigators (6), found that contrast echocardiog- 
raphy is useful in identifying arteriovenous malformations. 
In the presence of a pulmonary arteriovenous fistula, con- 
trast medium injected into a peripheral vein will appear in 
the left side of the heart. The delay in appearance of contrast 
in the left heart chambers, compared with the time of 
appearance in the right heart chambers. helps differentiate 
extracardiac from intracardiac shunts (7). 
Evaluation of therapy. In some situations, contrast echo- 
cardiography can be helpful in evaluating the results of 
therapy. The improvement of atria1 level mixing due to 
Rashkind balloon septostomy can be better assessed by 
contrast echocardiography than by Doppler imaging. 
Future applications. With the development of new con- 
trast agents like sonicated albumin (8). and the introduction 
of commercial agents such as Albunex (Molecular Biosys- 
terns) and Echovist (Schering), the applications of contrast 
echocardiography are expanding. Sonicated albumin is non- 
toxic and can transit the pulmonary circulation after intra- 
venous injection. The way is opened for improved automatic 
edge detection algorithms using left heart contrast enhance- 
ment. Time-intensity curves created by videodensitometry 
are correlated with blood flow giving contrast echocardiog- 
raphy a quantitative ability. Contrast medium can be used to 
enhance low intensity Doppler signals. thereby bringing out 
information on Doppler studies otherwise not available 
because of a poor signal to noise ratio. Perhaps the most 
exciting application of contrast echocardiography in adult 
and in some pediatric patients with congenital malformations 
is in myocardial perfusion imaging. Over the past 5 years this 
use has been validated in animal and human studies, al- 
though adequate myocardial perfusion imaging in humans 
currently requires left heart injections. 
Conclusions. Many of the initial uses of contrast echocar- 
diography have been replaced by Doppler echocardiog- 
raphy. However, the review by Van Hare and Silverman (4) 
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makes it clear that contrast echocardiography has continued 
utility in the diagnosis of congenital heart disease. New 
contrast agents and quantitative methods of contrast mea- 
surement will further expand the applications of contrast 
echocardiography during the 1990s. 
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